Expression and functional characterisation of a human chimeric nicotinic receptor with α6β4 properties

European Journal of Pharmacology

Volumn 466, Issue 1-2, 2003, Pages 31-39

  Evans, Non M ^a   Bose, Suchira ^a   Benedetti, Giovanni ^a   Zwart, Ruud ^a   Pearson, Kathy H ^a   McPhie, Gordon I ^a   Craig, Peter J ^a   Benton, Jason P ^a   Volsen, Stephen G ^a   Sher, Emanuele ^a   Broad, Lisa M ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

(Human); Chimera; HEK 293 cell; Nicotinic receptor; 6 Subunit

Indexed keywords

1,1 DIMETHYL 4 PHENYLPIPERAZINIUM; ACETYLCHOLINE; CONOTOXIN; CYTISINE; EPIBATIDINE; LIGAND; METHYLLYCACONITINE; NICOTINE; NICOTINIC RECEPTOR; RECEPTOR SUBUNIT;

ALPHA CHAIN; ANIMAL CELL; ARTICLE; BETA CHAIN; CELL LINE; CHIMERA; CONTROLLED STUDY; DRUG POTENCY; FLUORESCENCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMAGING; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; XENOPUS LAEVIS;

EID: 12244252748     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01540-1     Document Type: Article

References (41)

1. Astles P.C., Baker S.R., Boot J.B., Broad L.M., Dell C.P., Keenan M. Recent progress in the development of subtype selective nicotinic receptor ligands. Current Drug Targets-CNS and Neurological Diseases. 1:2002;427-438.
2. Azam L., Winzer-Serhan U.H., Chen Y., Leslie F.M. Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurones. J. Comp. Neurol. 444:2002;260-274.
3. Barabino B., Vailati S., Moretti M., McIntosh J.M., Longhi R., Clementi F., Gotti C. An α4β4 nicotinic receptor subtype is present in chick retina: identification, characterization and pharmacological comparison with the transfected α4β4 and α6β4 subtypes. Mol. Pharmacol. 59:2001;1410-1417.
4. Cartier G.E., Yoshikami D., Gray W.R., Luo S., Olivera B.M., McIntosh J.M. A new α-conotoxin which targets α3β2 nicotinic acetylcholine receptors. J. Biol. Chem. 271:1996;7522-7528.
5. Champtiaux N., Han Z.-Y., Bessis A., Rossi F.M., Zoli M., Marubio L., McIntosh J.M., Changeux J.-P. Distribution and pharmacology of α6-containing nicotinic acetylcholine receptors analysed with mutant mice. J. Neurosci. 22:2002;1208-1217.
6. Chavez-Noriega L.E., Crona J.H., Washburn M.S., Urrutia A., Elliot K.J., Johnson E.C. Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors hα2β2, hα2β4, hα3β2, hα3β4, hα4β2, hα4β4 and hα7 expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther. 280:1997;346-356.
7. Clarke P.B., Fu D.S., Jakubovic A., Fibiger H.C. Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats. J. Pharmacol. Exp. Ther. 246:1988;701-708.
8. Clementi F., Fornasari D., Gotti C. Neuronal nicotinic receptors, important new players in brain function. Eur. J. Pharmacol. 393:2000;3-10.
9. Dani J.A. Overview of nicotinic receptors and their roles in the central nervous system. Biol. Psychiatry. 49:2001;166-174.
10. Dineley-Miller K., Patrick J. Gene transcripts for the nicotinic acetylcholine receptor subunit, β4, are distributed in multiple areas of the rat central nervous system. Mol. Brain Res. 16:1992;339-344.
11. Elliot K.J., Ellis S.B., Berckhan K.J., Urrutia A., Chavez-Noriega L.E., Johnson E.C., Velicelebi G., Harpold M.M. Comparative structure of human neuronal α2-α7 and β2-β4 nicotinic acetylcholine receptor subunits and functional expression of the α2,α3,α4,α7,β2, and β4 subunits. J. Mol. Neurosci. 7:1996;217-228.
12. Fucile S., Matter J.-M., Erkman L., Ragozzino D., Barabino B., Grassi F., Alema S., Ballivet M., Eusebi F. The neuronal α6 subunit forms functional heteromeric acetylcholine receptors in human transfected cells. Eur. J. Neurosci. 10:1998;172-178.
13. Gerzanich V., Kuryatov A., Anand R., Lindstrom J. "Orphan" α6 nicotinic AChR subunit can form a functional heteromeric acetylcholine receptor. Mol. Pharmacol. 51:1997;320-327.
14. Goldner F.M., Dineley K.T., Patrick J.W. Immunohistochemical localization of the nicotinic acetylcholine receptor subunit α6 to dopaminergic neurones in the substantia nigra and ventral tegmental area. NeuroReport. 8:1997;2739-2742.
15. Han Z.Y., Le Novere N., Zoli M., Hill J.A., Champtiaux N., Changeux J.P. Localization of nAChR subunit mRNAs in the brain of Macaca mulatta. Eur. J. Neurosci. 12:2000;3664-3674.
16. Hussy N., Ballivet M., Bertrand D. Agonist and antagonist effects of nicotine on chick neuronal nicotinic receptors are defined by α and β subunits. J. Neurophysiol. 72:1994;1317-1326.
17. Jeyarasasingam G., Tompkins L., Quik M. Stimulation of non-α7 nicotinic receptors partially protects dopaminergic neurons from 1-methyl-4-phenylpyridinium-induced toxicity in culture. Neurosci. 109:2002;275-285.
18. Johnson L.R., Evans N.M., Bose S., Craig P.J., O'Neill M.J., Sher E., Gotti C., Volsen S.G. An immunohistochemical study of the distribution of the nicotinic acetylcholine receptor β4 subunit in adult rat brain. Br. J. Pharmacol. 135:2002;. Proc. Supp., 356 p.
19. Jones S., Sudweeks S., Yakel J.L. Nicotinic receptors in the brain: correlating physiology with function. Trends Neurosci. 22:1999;5555-5561.
20. Kulak J.M., Nguyen T.A., Yoshikami D., Olivera B.M., McIntosh J.M. α-Conotoxin MII blocks nicotine-stimulated dopamine release from rat striatal synaptosomes. J. Neurosci. 17:1997;5263-5270.
21. Kuryatov A., Olale F., Cooper J., Vhoi C., Lindstrom J. Human α6 AChR subtypes: subunit composition, assembly, and pharmacological responses. Neuropharmacology. 39:2000;2570-2590.
22. Lamar E., Millar K., Patrick J. Amplification of genomic sequences identifies a new gene, a6, in nicotinic acetylcholine receptor gene family. Soc. Neurosci. Abstr. 16:1990;681. (285.2).
23. Le Novere N., Zoli M., Changeux J.-P. Neuronal nicotinic receptor α6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of rat brain. Eur. J. Neurosci. 8:1996;2428-2439.
24. Le Novere N., Zoli M., Lena C., Ferrari R., Picciotto M.R., Merlo-Pich E., Changeux J.-P. Involvement of α6 nicotinic receptor subunit in nicotinic-elicited locomotion, demonstrated by in vivo antisense oligonucleotide infusion. NeuroReport. 10:1999;2497-2501.
25. Levin E.D., Simon B.B. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology. 138:1998;217-230.
26. Lewis T.M., Harkness P.C., Sivilotti L.G., Colquhoun D., Millar N.S. The ion channel properties of a rat recombinant neuronal nicotinic receptor are dependent on the host cell type. J. Physiol. 505.2:1997;299-306.
27. Lindstrom J. The structure of nAChRs. Clementi F., Fornasari D., Gotti C. Neuronal Nicotinic Receptors. Handbook of Experimental Pharmacology. vol. 144:2000;101-184 Springer-Verlag, Berlin.
28. McGehee D.S., Role L.W. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurones. Annu. Rev. Physiol. 57:1995;521-546.
29. Meyer E.M., Kuryatov A., Gerzanich V., Lindstrom J., Papke R.L. Analysis of 3-(4-hydroxy, 2-methoxybenzylidene) anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptors. J. Pharmacol. Exp. Ther. 287:1998;918-925.
30. Picciotto M.R., Zoli M., Léna C., Bessis A., Lallemand Y., Le Novère N., Vincent P., Merlo Pich E., Brulet P., Changeux J.P. Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature. 374:1995;65-67.
31. Picciotto M.R., Zoli M., Rimondini R., Lena C., Marubio L.M., Pich E.M., Fuxe K., Changeux J.P. Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature. 391:1998;173-177.
32. Pontieri F.E., Tanda G., Orzi F., Di Chiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature. 382:1996;401-404.
33. Quik M., Kulak J. Nicotine and nicotinic receptors; relevance to Parkinson's disease. Neuro. Toxicol. 131:2002;1-14.
34. Quik M., Polonskaya Y., Gillespie A., Jakowec M., Lloyd G.K., Langston J.W. Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridisation. J. Comp. Neurol. 425:2000;58-69.
35. Quik M., Polonskaya Y., Gillespie A., Lloyd G.K., Langston J.W. Differential alterations in nicotinic receptor α6 and β3 subunit messenger RNAs in monkey substantia nigra after nigrostriatal degeneration. Neurosci. 100:2000;63-72.
36. 125I-α-conotxin MII binding sites to nigrostriatal damage in monkey. J. Neurosci. 21:2001;5500-5594.
37. Quik M., Polonskaya Y., McIntosh J.M., Kulak J.M. Differential nicotinic receptor expression in monkey basal ganglia: effects of nigrostriatal damage. Neurosci. 112(3):2002;619-630.
38. Stauderman K.A., Mahaffy L.S., Akong M., Velicelebi G., Chavez-Noriega L.E., Crona J.H., Johnson E.C., Elliot K.J., Gillespie A., Reid E.T., Adams P., Harpold M.M., Corey-Naeve J. Characterization of human recombinant neuronal nicotinic acetylcholine receptor subunit combinations α2β4, α3β4 and α4β4 stably expressed in HEK293 cells. J. Pharmacol. Exp. Ther. 284:1998;777-789.
39. Stitzel J.A., Jimenez M., Marks M.J., Tritto T., Collins A.C. Potential role of the α4 and α6 nicotinic receptor subunits in regulating nicotine-induced seizures. J. Pharmacol. Exp. Ther. 293:2000;27-74.
40. Vailati S., Hanke W., Bejan A., Barabino B., Longhi R., Balestra B., Moretti M., Clemento F., Gotti C. Functional α6-containing nicotinic receptors are present in chick retina. Mol. Pharmacol. 56:1999;11-19.
41. Whiteaker P., Sharples C.G.V., Wonnacott S. Agonist induced up-regulation of α4β2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition. Mol. Pharmacol. 53:1998;950-962.